343 related articles for article (PubMed ID: 17659562)
1. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
2. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction.
Lupo JM; Lee MC; Han ET; Cha S; Chang SM; Berger MS; Nelson SJ
J Magn Reson Imaging; 2006 Sep; 24(3):520-9. PubMed ID: 16888776
[TBL] [Abstract][Full Text] [Related]
4. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
5. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla.
Hattingen E; Pilatus U; Franz K; Zanella FE; Lanfermann H
J Magn Reson Imaging; 2007 Aug; 26(2):427-31. PubMed ID: 17654728
[TBL] [Abstract][Full Text] [Related]
8. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic imaging of the brain with phased-array coils at 3.0 T.
Xu D; Chen AP; Cunningham C; Osorio JA; Nelson SJ; Vigneron DB
Magn Reson Imaging; 2006 Jan; 24(1):69-74. PubMed ID: 16410180
[TBL] [Abstract][Full Text] [Related]
10. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
11. Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil.
Tsai SY; Otazo R; Posse S; Lin YR; Chung HW; Wald LL; Wiggins GC; Lin FH
Magn Reson Med; 2008 May; 59(5):989-98. PubMed ID: 18429025
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
13. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors.
Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y
Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe.
Arslanoglu A; Bonekamp D; Barker PB; Horská A
J Magn Reson Imaging; 2004 Nov; 20(5):772-8. PubMed ID: 15503328
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain.
Lin FH; Tsai SY; Otazo R; Caprihan A; Wald LL; Belliveau JW; Posse S
Magn Reson Med; 2007 Feb; 57(2):249-57. PubMed ID: 17260356
[TBL] [Abstract][Full Text] [Related]
18. TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.
Srinivasan R; Cunningham C; Chen A; Vigneron D; Hurd R; Nelson S; Pelletier D
Neuroimage; 2006 May; 30(4):1171-8. PubMed ID: 16431138
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopic imaging of the medulla and cervical spinal cord.
Edden RA; Bonekamp D; Smith MA; Dubey P; Barker PB
J Magn Reson Imaging; 2007 Oct; 26(4):1101-5. PubMed ID: 17896355
[TBL] [Abstract][Full Text] [Related]
20. [Spectroscopic imaging of the brain. Examination technique and clinical applications].
Heindel W; Kugel H; Lanfermann H; Landwehr P; Krahe T; Lackner K
Nervenarzt; 1995 Dec; 66(12):895-900. PubMed ID: 8584073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
